Ubiquitin-dependent protein disposal may preserve tissue function despite defective mitophagy
Inhibiting mechanistic target of rapamycin (mTOR) may protect several tissues by accelerating disposal of damaged proteins outside mitochondria despite blocked mitophagy. Benefit without extra destruction of the relevant proteins would refute this mechanism.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Enzyme
mTOR
A protein whose suppression reduces excessive transcription of ribosomal genes in the proposed pathway
Where this hypothesis actsAcross multiple tissues with persistent defective mitophagy
Hypotheses on this target 4
Inhibition4
Activation
Lower level
Higher level
Replacement
Protection from degradation
Cofactor removal
Synthesis suppression
Function preservation

What is proposed
Inhibition
Suppress mTOR to increase degradation of damaged proteins
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible sustained functional benefit through clearance of damaged proteins outside mitochondria
From the recordПодавление mTOR повышает убиквитинирование и протеасомное разрушение повреждённых долгоживущих белков вне митохондрий.

Metabolism and energy
Ubiquitin-dependent proteasomal degradation
The breakdown of ubiquitin-marked proteins by the proteasome
Where this hypothesis actsDamaged long-lived proteins outside mitochondria, across multiple tissues with defective mitophagy
Hypotheses on this target 1
Inhibition
Activation1
Function preservation
Supplementation
Feedback restoration
Direct measurement

What is proposed
Activation
Increase ubiquitin-dependent degradation of damaged proteins
With whatNot stated in the record
HowSuppress mTOR; the regulator or substrate set responsible for the additional degradation remains to be identified
Possible result
Possible restoration of enzyme and contractile function despite persistent defective mitophagy
From the recordНакопление повреждённых белков служит причинным субстратом, а протеасомный поток является необходимым посредником.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Several parts of an aging body might benefit from removing the same kind of accumulated damage. The unexpected move is to propose that clearing damaged proteins outside mitochondria, the cell structures that convert nutrients into usable energy, could preserve tissue function even when removal of damaged mitochondria remains defective. This is a hypothesis generated by the pipeline, not a measured result.
- Suppressing mTOR is proposed to increase disposal tags on damaged, long-lived proteins outside mitochondria.
- Those tags are proposed to direct more of the damaged proteins into proteasomes for destruction.
- Faster destruction is proposed to reduce the accumulated damaged proteins while mitochondrial removal remains defective.
- Removing the damaged proteins is proposed to restore chemical reactions and contraction in several tissues.
- Restored tissue function is predicted to produce lasting benefits beyond delaying a single tumor-related cause of death.
A workshop could regain useful space by clearing broken tools even while its service for removing broken generators remains out of action.
Where the picture breaks: The picture assumes that broken tools obstruct work and that removing them restores it. The biological proposal must establish both points for the particular damaged proteins, and removal alone does not explain how working proteins replace them.
- Master questionstep 01 of 04
Aging processes may reinforce one another, so targeting a shared cause could benefit several body systems at once.
Rests on: The goal takes the possibility of a shared, treatable cause as the basis for generating life-extension ideas.
AssumptionThe supplied goal assumes that a shared causal link could be targeted for benefits across systems; it does not establish a particular link or intervention.
- Goal pillarstep 02 of 04
The intended output is a set of life-extension ideas that act through distinct causal routes.
Rests on: The master question explicitly requests ideas for shared targets that could benefit several aging systems.
Stated in the chain - Gap questionstep 03 of 04
Life extension from suppressing mTOR might persist after disabling mitophagy, the selective removal of mitochondria, even if damage continues to amplify between body systems and the entire survival benefit comes from delaying one cause of death.
Rests on: The preceding goal calls for distinct causal explanations, but does not introduce this treatment, its proposed mitochondrial route, or the conditions used to challenge that route.
LeapThe supplied chain does not explain the selection of mTOR suppression and mitophagy from the broader goal. The screened sources do not establish the combined situation of continued life extension, disabled mitophagy, unchanged amplification of damage between systems, and benefit attributable to one cause of death.
- Hypothesisstep 04 of 04
Suppressing mTOR is proposed to increase ubiquitination, the attachment of a protein tag that can direct disposal, and destruction of damaged, long-lived proteins by the proteasome, a cellular protein-cutting machine. Removing these proteins outside mitochondria is proposed to restore enzymes, proteins that speed up chemical reactions, and the machinery that produces contraction in several tissues despite defective mitophagy.S3S6S7
Rests on: The gap question leaves room for a route that works despite defective mitochondrial removal. S3, in FASEB BioAdvances in 2024, reports increased destruction of tristetraprolin, a protein that regulates the persistence of cellular messages, after mTOR inhibition in infected immune cells; it does not establish clearance of damaged, long-lived proteins or benefits across tissues. S6, in The Journal of Biological Chemistry in 2024, describes disposal of irreversibly damaged proteins, without establishing this treatment or its proposed benefits. S7, in the same journal in 2022, reports longer life and greater resistance to damaging conditions after increasing proteasome activity in roundworms, alongside reduced offspring production; it does not establish the proposed route in old animals with defective mitophagy.
Supported by literature
What is carried, and what is not. The screened literature provides partial backing for two broad parts of the proposed mechanism: altered protein disposal after mTOR suppression and protection associated with greater proteasome activity. It does not establish the sequence end to end; S5, a 2023 review in Cells, also reports that rapamycin treatment reduced elevated expression of proteasome components in genetically altered mouse muscle, which challenges a simple expectation of uniformly increased disposal but does not measure the specific damaged-protein removal proposed here.S5
Where the reasoning is carried by something unstated · 2
- Master question. The supplied goal assumes that a shared causal link could be targeted for benefits across systems; it does not establish a particular link or intervention.
- Gap question. The supplied chain does not explain the selection of mTOR suppression and mitophagy from the broader goal. The screened sources do not establish the combined situation of continued life extension, disabled mitophagy, unchanged amplification of damage between systems, and benefit attributable to one cause of death. Establish the missing link before relying on this step.
How a result here could mislead · 3
- More ubiquitin tags could be mistaken for faster destruction of the tagged proteins. Tag accumulation alone does not show that disposal has been completed. What closes it: The proposed isotope label, a chemically distinguishable marker used to follow existing proteins, must track the disappearance of the relevant previously labeled damaged proteins over time. Tag measurements must be interpreted alongside that removal rate.
- Loss of protection after broadly suppressing proteasomes could be attributed to removal of the proposed protective route when it instead reflects toxicity from disrupting ordinary protein disposal. What closes it: The specification requires identifying the regulator or protein targets responsible for the treatment-induced increase before testing necessity. The intervention must selectively remove that increase, preserve mTOR suppression and the specified changes in production of cellular messages, and distinguish loss of protection from damage caused by the intervention itself; independent restoration of disposal must return protection.
- Longer survival could be credited to protection across tissues even if treatment only delays a fatal tumor, leaving the central distinction in the gap question unresolved. What closes it: Survival must be assessed alongside sustained function in several tissues and the causes of death. The supplied specification predicts such functional benefit but does not name the tissue measurements, observation period, or criteria that would distinguish it from postponing one fatal disease.
What would make this wrong. The hypothesis would be contradicted if functional protection persisted despite verified absence of the treatment-induced increase in destruction of the relevant damaged proteins. That observation would break the claimed requirement for extra protein disposal even if mTOR suppression still improved survival or tissue function.
What it would change. If the proposed sequence held, damaged-protein accumulation would become a candidate shared cause whose removal preserves several tissues despite defective mitochondrial removal. Work on a life-extending shared target would then have to distinguish this disposal route from mitochondrial removal and from postponement of a single fatal disease. Even a successful functional test would not by itself establish longer life, reduced amplification of damage between organs, or benefits in humans.
Sources read · 10
Reversing Autophagy Inhibition Ameliorates Neurodegeneration in Hereditary Spastic Paraplegia Caused by a Degradation-Resistant SPAST Mutation. · Movement disorders : official journal of the Movement Disorder Society · 2026
“Rapamycin restored autophagy, decreased p62 levels, and reduced cell death.”
Does not settle: It does not establish mTOR inhibition increases ubiquitination or proteasomal degradation, preserves function despite defective mitophagy, restores enzymes or contractile machinery across tissues, or that proteasomal flux is a necessary mediator of sustained functional benefit.
HSP70 promotes amino acid-dependent mTORC1 signaling by mediating CHIP-induced NPRL2 ubiquitination and degradation. · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
“Taken together, these results demonstrated that HSP70 is a novel activator of mTORC1 through mediating CHIP-induced ubiquitination and degradation of NPRL2.”
Does not settle: Источник не исследует подавление mTOR, повреждённые долгоживущие белки вне митохондрий, дефект митофагии, восстановление функций тканей или необходимость протеасомного потока для такой пользы.
Tristetraprolin mediates immune evasion of mycobacterial infection in macrophages. · FASEB bioAdvances · 2024
“These results indicate that inhibition of the mTOR signaling pathway promotes TTP degradation through a ubiquitin/proteinase‐dependent mechanism.”
Does not settle: The source studies BCG-infected macrophages and TTP. It does not establish removal of damaged long-lived proteins, preservation of enzyme or contractile function across tissues, persistent mitophagy defects, or a benefit beyond infection-related outcomes.
Dysfunction of Avo3, an essential component of target of rapamycin complex 2, induces ubiquitin-proteasome-dependent downregulation of Avo2 in Saccharomyces cerevisiae. · Biochemical and biophysical research communications · 2024
“Here we report a functional interplay between the UPS and TORC2 in Saccharomyces cerevisiae.”
Does not settle: Источник не изучает подавление mTOR, повреждённые долгоживущие белки вне митохондрий, митофагию, функцию ферментов или сократительного аппарата, несколько тканей либо устойчивую функциональную пользу.
Age-Related Dysfunction in Proteostasis and Cellular Quality Control in the Development of Sarcopenia. · Cells · 2023
“Skeletal muscle from TSC1-knockout mice exhibit greater expression of several atrogenes and components of the 26S proteasome that is reversed by acute 3-day treatment with rapamycin.”
Does not settle: Остаются открытыми убиквитинирование и разрушение повреждённых долгоживущих белков вне митохондрий, сохранение дефекта митофагии, восстановление функций в нескольких тканях, причинная роль накопления белков, необходимость протеасомного потока и долговременная функциональная польза.
Redox regulation of proteostasis. · The Journal of biological chemistry · 2024
“cells must eliminate oxidized proteins that are irreversibly damaged by targeting them for degradation either by the proteasome or by the autophagy/lysosomal machinery”
Does not settle: The source does not establish mTOR suppression, ubiquitination or proteasomal flux as a necessary mediator, clearance of long-lived non-mitochondrial proteins, persistent mitophagy defects, restoration of enzyme or contractile function across tissues, or durable organismal functional benefit.
Hyperactivation of the proteasome in Caenorhabditis elegans protects against proteotoxic stress and extends lifespan. · The Journal of biological chemistry · 2022
“We determined these nematodes showed a significantly increased lifespan and substantial resistance to oxidative and proteotoxic stress but a significant decrease in fecundity.”
Does not settle: This Caenorhabditis elegans proteasome-gate mutation study does not test mTOR inhibition, defective mitophagy, damaged long-lived proteins outside mitochondria, restoration of enzymes or contractile machinery across tissues, or whether proteasomal flux is necessary for those outcomes.
HSP70 Inhibition Leads to the Activation of Proteasomal System under Mild Hyperthermia Conditions in Young and Senescent Fibroblasts. · Oxidative medicine and cellular longevity · 2020
“However, when HSP70 expression was inhibited, the proteasome activity was found to increase to maintain protein homeostasis.”
Does not settle: This source does not test mTOR suppression, ubiquitination, mitophagy defects, removal of damaged long-lived proteins, restoration of enzyme or contractile function, causality of protein accumulation, proteasome necessity, multiple tissues, or sustained organism-level functional benefit.
UVB-Induced Senescence of Human Dermal Fibroblasts Involves Impairment of Proteasome and Enhanced Autophagic Activity. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2017
“We provide evidence that the inhibition of proteasomal degradation of damaged proteins and the activation of autophagosome formation are early events in UVB-induced senescence of HDFs, dependent on UVB-induced accumulation of reactive oxygen species.”
Does not settle: Источник не исследует подавление mTOR, убиквитинирование, митофагию, восстановление функции ферментов или сократительного аппарата, необходимость протеасомного потока и пользу в нескольких тканях.
The yeast mitophagy receptor Atg32 is ubiquitinated and degraded by the proteasome. · PloS one · 2020
“Atg32 turnover can be prevented by inhibition of the proteasome”
Does not settle: Источник описывает протеасомный распад рецептора митофагии Atg32 у дрожжей. Он не устанавливает влияние подавления mTOR на повреждённые долгоживущие белки вне митохондрий, восстановление функций тканей, сохранение дефекта митофагии или необходимость протеасомного потока для такой пользы.
The gap this hypothesis explains
Two live hypotheses pull in opposite directions here, and the field has not chosen between them.
Does blocking a growth-control protein still extend mouse life when damaged cell powerhouses cannot be cleared?
Original wording · exactly as the pipeline generated it
Сохранится ли продление жизни при подавлении mTOR после выключения предполагаемого посредника, митофагии, если межсистемное усиление повреждений останется прежним, а весь выигрыш объяснит отсрочка одной причины смерти?
What this question is asking
The question asks whether removing damaged energy-producing structures inside cells is necessary for a treatment to extend mouse life. It concerns suppression of mammalian target of rapamycin (mTOR), a protein involved in controlling cell growth, after disabling mitophagy, the process that removes those structures. The relevant comparison is whether suppression still increases remaining lifespan relative to no suppression when this removal process is disabled, compared with when it remains available. The question also considers a conditional explanation: damage in different body systems might continue to worsen other systems' damage, while the entire survival benefit comes from postponing just one cause of death.
- Mammalian target of rapamycin (mTOR)
- A protein involved in controlling cell growth. Suppression means reducing its activity; the question asks whether the resulting lifespan effect requires removal of damaged cellular powerhouses.
- Mitochondria
- Structures inside cells involved in producing usable energy, described here as cellular powerhouses. Their removal is the proposed link between treatment and longer life.
- Mitophagy
- The cellular process that removes mitochondria, including damaged ones. The question treats it as a possible necessary step in the lifespan effect, which the supplied sources do not establish.
- Autophagy
- The broader cellular process for removing and recycling material within cells. Mitophagy is the mitochondria-focused form; a finding about the broader process does not automatically establish the particular role of mitophagy.
- Mediator and mediation
- A mediator is an intermediate process through which an intervention causes an outcome. Here, mediation would mean that suppression of mTOR extends life through its effect on mitophagy, rather than the two simply being associated.
- Intersystem damage amplification
- The proposed process in which damage in one body system worsens damage in another. Its persistence during treatment is a condition considered by the question, not a finding established by the supplied sources.
- Rapamycin
- The treatment evaluated in the mouse lifespan findings quoted in S2. Those findings describe survival responses but do not establish the proposed role of mitophagy.
- Corylin
- The compound studied in S3. The supplied quotation reports a lifespan benefit in female mice without a comparable benefit in males.
- Median lifespan
- The time by which half of a studied group has died. It summarizes survival and does not identify which causes of death changed.
- Survival rate at a stated age
- The proportion of a group still alive at that age. S3 reports a comparison at 125 weeks; the supplied quotation does not give the underlying proportions.
- Mouse strain
- A mouse breeding line with a particular inherited background. S2 reports that strain influences the size of the lifespan response.
- Kisspeptin-10
- The molecule used in S5 to stimulate cellular removal processes. The supplied quotation describes a route independent of mTOR, so it does not establish mediation of a treatment that suppresses mTOR.
- Cellular signaling
- Processes through which activity in one part of a cell changes activity elsewhere in it. A signaling connection alone does not establish an effect on whole-animal lifespan.
- Human neuronal cell line
- Human cells maintained in laboratory culture and used to study nerve-cell processes. Findings in these cells do not by themselves establish survival effects in an animal.
- Hippocampus and cultured hippocampal tissue
- The hippocampus is a brain region. Cultured hippocampal tissue is tissue from that region maintained outside the animal; S5 includes this preparation alongside cell cultures and aging rats.
mTOR suppression is associated with longer mouse survival, mitophagy is its proposed cellular mediator, and the survival gain might occur with unchanged intersystem damage amplification because only one cause of death is delayed.
The proposed explanation places removal of damaged cellular powerhouses between blocking a growth-control protein and longer life. It contrasts protection across several body systems with a scenario in which damage still spreads between systems but one fatal condition occurs later. Establishing these links would distinguish a shared protective process from a narrower explanation of longer survival.
S2 reports generally favorable mouse lifespan findings for rapamycin, and S3 reports longer life in female mice receiving corylin. Neither supplied quotation establishes that removal of damaged cellular structures mediates those benefits. S5 instead reports stimulation of that removal through a route independent of mTOR; it does not establish the proposed mediation. None of the supplied sources establishes unchanged damage amplification between systems or a survival gain fully explained by delaying one cause of death. Those last conditions are hypothetical in the question, and this background-focused selection is too limited to establish or refute the complete premise.S2S3S5
The same question asked without the part nothing read establishes:
- Does suppressing the growth-control protein extend mouse life when removal of damaged cellular powerhouses is disabled?
- Does longer mouse life under suppression of the growth-control protein reflect lasting benefits across several body systems or postponement of one cause of death?
- The lifespan benefit persists Under the question's assumption that removal of damaged cellular powerhouses has been disabled, a persisting benefit would mean that this removal is not necessary for the entire survival effect. If postponement of one cause of death accounts for all of that benefit, longer life would not by itself demonstrate protection across several body systems.
- The lifespan benefit disappears Losing the benefit would be consistent with the removal process being necessary for the survival effect in the stated conditions. That result alone would still not establish that the process protects several systems or interrupts damage spreading between them.
- The lifespan benefit becomes smaller A smaller benefit would be consistent with the removal process contributing to, but not fully accounting for, longer survival. The remaining benefit would still need to be distinguished from the question's alternative explanation of postponing one cause of death.
The proposed explanation links suppression of the growth-control protein to removal of damaged cellular structures, then to lasting benefits across several body systems, and finally to longer life. Each connection matters because longer survival alone does not establish the preceding steps. Under the question's alternative explanation, postponing one fatal disease could extend life while damage elsewhere continues. Mistaking that outcome for protection across several systems would overstate what the survival findings establish.
Подавление mTOR уровня RL-2 связано с мышиной выживаемостью; митофагическое посредничество уровня RL-1 показано на клетках.
Выигрыш оставшейся жизни должен сопровождаться устойчивой пользой нескольким системам и проверенным общим посредничеством за единый горизонт наблюдения.
Не установлено, объясняет ли митофагия многосистемный выигрыш жизни; подавление отдельной смертельной патологии может воспроизводить наблюдаемую выживаемость.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Подавление mTOR повышает убиквитинирование и протеасомное разрушение повреждённых долгоживущих белков вне митохондрий. Удаление этих белков восстанавливает работу ферментов и сократительного аппарата в нескольких тканях даже при сохраняющемся дефекте митофагии. Накопление повреждённых белков служит причинным субстратом, а протеасомный поток является необходимым посредником. Эта версия предсказывает устойчивую функциональную пользу, выходящую за пределы отсрочки одной опухолевой причины смерти.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
После выключения митофагии сохраняются ускоренное разрушение заранее меченых повреждённых цитозольных белков и функциональная польза. Устранение именно вызванного лечением прироста убиквитин-зависимого разрушения отменяет пользу, хотя подавление mTOR и изменения транскрипции рибосомных генов сохраняются. Независимое восстановление протеасомного потока возвращает защиту. Сохранение пользы при отсутствии дополнительного разрушения соответствующих белков опровергает гипотезу.
States a measurable outcome; comparing rivals needs more conditions. The text specifies observable persistence, loss, and restoration of benefit under stated conditions, plus an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Скорость разрушения белков можно измерять по изотопной метке и убиквитиновым модификациям. Общее подавление протеасомы токсично и не является чистой проверкой посредничества. Сначала необходимо определить регулятор или набор субстратов, обеспечивающий дополнительный поток, и лишь затем проверять его необходимость в старых животных.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
После выключения митофагии сохраняются ускоренное разрушение заранее меченых повреждённых цитозольных белков и функциональная польза. Устранение именно вызванного лечением прироста убиквитин-зависимого разрушения отменяет пользу, хотя подавление mTOR и изменения транскрипции рибосомных генов сохраняются. Независимое восстановление протеасомного потока возвращает защиту. Сохранение пользы при отсутствии дополнительного разрушения соответствующих белков опровергает гипотезу.
- What would separate them
Rapamycin may extend life by changing calcium control of breathing-muscle contraction predicts: При подтверждённой блокаде митофагии рапамицин сохраняет выигрыш оставшейся жизни и повышает устойчивость диафрагмы к повторным сокращениям. Сопоставимое подавление mTOR генетическим способом этого результата не воспроизводит. Лиганд FKBP12, сохраняющий необходимое кальциевое действие и не подавляющий mTOR, воспроизводит оба эффекта. Избирательное устранение кальциевого действия рапамицина отменяет выигрыш при сохранённом подавлении mTOR. Сохранение пользы генетического подавления mTOR после такого устранения опровергает гипотезу.
- What would separate them
Growth-signal inhibition may release a brake on protein kinase B and limit cell death predicts: После блокады митофагии сохраняются краткий ответ AKT, уменьшение апоптоза после повторной нагрузки и замедление функционального ухудшения нескольких систем. Избирательное устранение вызванного лечением ответа AKT отменяет эти эффекты при сопоставимом подавлении mTOR. Модель, построенная по ответам на одиночные слабые нагрузки, заранее предсказывает меньший пик повреждения при их сочетании. Если защита сохраняется при устранённом ответе AKT либо измеренный ответ усиливает повреждение, гипотеза отвергается.
- Rival 03 of 04What would separate them
Lysosomal acidity may mimic faster mitochondrial removal predicts: Изменение сигнала mt-Keima объясняется независимо измеренной кислотностью и количеством ранее накопленного репортёра. После соответствующей калибровки увеличение потока исчезает; независимое отслеживание доставки и разрушения меченых митохондрий также не выявляет ускорения. При этом подавление mTOR замедляет рост опухоли даже после устранения дополнительных механизмов остальных гипотез. Длительные траектории заранее выбранных неопухолевых функций остаются прежними. Подтверждение ускоренного удаления целых митохондрий независимыми методами опровергает оптическую часть гипотезы.
- What would separate them
Reducing ribosomal gene transcription may protect tissues by limiting genome damage predicts: При подавленной митофагии лечение уменьшает гибриды РНК и ДНК и новые разрывы в рибосомных генах до появления функциональной пользы. Направленное удаление патологических гибридов рибонуклеазой H1 воспроизводит защиту и уменьшает дополнительный эффект рапамицина в диапазоне, свободном от потолочного эффекта. Избирательное восстановление исходного уровня гибридов при сохранённом подавлении mTOR отменяет защиту. Если лечение сохраняет функциональную и жизненную пользу при экспериментально восстановленном геномном повреждении, эта версия отвергается.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.